GlassScriptPhysician profile
Jana E Porteus
NPI 1407091978
$1,496.99
in general payments reported to CMS, 2019-2025
16 companies · $63.37 in 2025
The $63.37 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $310 · 2022: $404 · 2023: $278 · 2024: $442 · 2025: $63.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $782.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $406.60 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $280.43 | 2021-2025 | |
| Abbott Laboratories | $208.45 | 2021-2022 | |
| Boston Scientific Corporation | $163.58 | 2022-2024 | Lux-Dx Insertable Cardiac Monitor |
| Novo Nordisk INC | $89.85 | 2021-2025 | Wegovy, Ozempic |
| Chiesi USA, INC. | $82.75 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $67.41 | 2021-2024 | Lifevest |
| Biotronik INC. | $54.72 | 2021-2022 | |
| Esperion Therapeutics, INC. | $24.86 | 2024 | Nexletol |
| Astellas Pharma US INC | $22.04 | 2021 | |
| Impulse Dynamics (USA) INC. | $19.95 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $18.85 | 2023 | Arcalyst |
| Altathera Pharmaceuticals LLC | $18.54 | 2025 | Sotalol Hydrochloride |
| Medtronic, INC. | $17.42 | 2023 | Endurant Iis |
| Bardy Diagnostics, INC. | $15.00 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vivaquant INC, Dba Rhythm Express | $6.54 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jana Porteus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.